Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04664192 · ClinicalTrials.gov registry record
Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research
A clinical trial of Respiratory Failure and Interstitial Lung Disease, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT04664192: Recruiting study of Respiratory Failure and Interstitial Lung Disease, sponsored by Baylor Research Institute.
NCT04664192 is a study of Respiratory Failure and Interstitial Lung Disease that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 100 participants, below the 4,521-participant average among 40 other Respiratory Failure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04664192, a study of Respiratory Failure and Interstitial Lung Disease, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
A major goal of this protocol is to support biomarker studies in advanced lung diseases, lung transplantation care, and to improve our understanding of the effects of viral and other infectious exposures to outcomes in our lung transplant and ALD patient populations.
Primary Outcome
ICD 10 code for underlying lung disease
Conditions Studied
Interventions
- OTHER Patient Biospecimen Registry (observational and blood sampling)
Study Locations (1)
Texas
- Baylor Scott & White Research Institute - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-06-04 |
| Est. Completion | 2026-12-01 |
What NCT04664192 shows while recruiting
NCT04664192 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 4,521-participant average among 40 other Respiratory Failure trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Respiratory Failure appearing as the primary indexed condition, and to 1 intervention - of which Patient Biospecimen Registry (observational and blood sampling) is the first listed.
NCT04664192 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04664192 about?
NCT04664192 is a clinical study titled "Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research". A major goal of this protocol is to support biomarker studies in advanced lung diseases, lung transplantation care, and to improve our understanding of the effects of viral and other infectious exposures to outcomes in our lung transplant and ALD patient populations.
What is the current status of trial NCT04664192?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2021-06-04. Estimated completion is 2026-12-01.
What conditions does trial NCT04664192 study?
This clinical trial studies the following conditions: Respiratory Failure, Interstitial Lung Disease, Lung Diseases.
What interventions are being tested in trial NCT04664192?
The interventions under investigation include: Patient Biospecimen Registry (observational and blood sampling) (OTHER).
Who is sponsoring clinical trial NCT04664192?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04664192 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04664192's enrollment target sits among peer trials
100 25th of 40 higher than 14 of 40 other Respiratory Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Analgesia-First Sedation in Trauma Patients
RECRUITING · NA
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Supraglottic Airway for Resuscitation in Preemies
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
A Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI